Study to assess the bioequivalence between ticagrelor orodispersible tablets and ticagrelor immediate-release tablets in Japanese subjects

Trial Identifier:	D5139C00004
Sponsor:	AstraZeneca
NCTID::	NCT02436577
Start Date:	June 2015
Primary Completion Date:	August 2015
Study Completion Date:	August 2015
Condition:	Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.